HUP0201531A3 - Dinucleotide crystals and process for preparation thereof - Google Patents

Dinucleotide crystals and process for preparation thereof

Info

Publication number
HUP0201531A3
HUP0201531A3 HU0201531A HUP0201531A HUP0201531A3 HU P0201531 A3 HUP0201531 A3 HU P0201531A3 HU 0201531 A HU0201531 A HU 0201531A HU P0201531 A HUP0201531 A HU P0201531A HU P0201531 A3 HUP0201531 A3 HU P0201531A3
Authority
HU
Hungary
Prior art keywords
dinucleotide
crystals
preparation
dinucleotide crystals
Prior art date
Application number
HU0201531A
Other languages
English (en)
Original Assignee
Yamasa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamasa Corp filed Critical Yamasa Corp
Publication of HUP0201531A2 publication Critical patent/HUP0201531A2/hu
Publication of HUP0201531A3 publication Critical patent/HUP0201531A3/hu
Publication of HU229225B1 publication Critical patent/HU229225B1/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C07H1/06—Separation; Purification
HU0201531A 1999-06-30 2000-06-30 Dinucleotide crystals HU229225B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18495099 1999-06-30
PCT/JP2000/004336 WO2001002416A1 (fr) 1999-06-30 2000-06-30 Cristaux dinucleotidiques

Publications (3)

Publication Number Publication Date
HUP0201531A2 HUP0201531A2 (en) 2002-08-28
HUP0201531A3 true HUP0201531A3 (en) 2005-02-28
HU229225B1 HU229225B1 (en) 2013-09-30

Family

ID=16162200

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0201531A HU229225B1 (en) 1999-06-30 2000-06-30 Dinucleotide crystals

Country Status (22)

Country Link
US (1) US6617444B1 (hu)
EP (2) EP1362862B1 (hu)
JP (1) JP3421666B2 (hu)
KR (1) KR100593723B1 (hu)
CN (1) CN1144811C (hu)
AT (2) ATE255123T1 (hu)
AU (1) AU767136B2 (hu)
BR (1) BR0012205A (hu)
CA (1) CA2376860C (hu)
CZ (1) CZ303172B6 (hu)
DE (2) DE60021629T2 (hu)
EA (1) EA004707B1 (hu)
ES (2) ES2211566T3 (hu)
HU (1) HU229225B1 (hu)
IL (1) IL147163A (hu)
MX (1) MXPA02000035A (hu)
NO (1) NO321169B1 (hu)
NZ (1) NZ516301A (hu)
PL (2) PL202176B1 (hu)
SK (1) SK284178B6 (hu)
WO (1) WO2001002416A1 (hu)
ZA (1) ZA200110468B (hu)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7078391B2 (en) 1997-02-10 2006-07-18 Inspire Pharmaceuticals, Inc. Method of treating edematous retinal disorders
US7223744B2 (en) 1997-02-10 2007-05-29 Inspire Pharmaceuticals, Inc. Pharmaceutical formulation comprising dinucleoside polyphosphates and salts thereof
US6818629B2 (en) 1997-02-10 2004-11-16 Inspire Pharmaceuticals, Inc. Pharmaceutical formulation comprising P1-(2'-deoxycytidine 5'-)P4-(uridine 5'-) tetraphosphate
US6548658B2 (en) * 1997-07-25 2003-04-15 Inspire Pharmaceuticals, Inc. Di-(uridine 5′)-tetraphosphate and salts thereof
US6872710B2 (en) 1997-07-25 2005-03-29 Inspire Pharmaceuticals, Inc. Di(uridine 5′)-tetraphosphate and salts thereof
CZ303172B6 (cs) * 1999-06-30 2012-05-09 Inspire Pharmaceuticals, Inc. Krystalická forma P1-(2'-deoxycytidin-5'-)P4-(uridin-5'-)tetrafosfátu
US6867199B2 (en) 2000-08-21 2005-03-15 Inspire Pharmaceuticals, Inc. Dinucleoside polyphosphate compositions and their therapeutic use
US7161029B2 (en) * 2003-12-17 2007-01-09 Ajinomoto Co., Inc. DiL-lysine monosulfate trihydrate crystal and method of making
CN100363376C (zh) * 2006-06-12 2008-01-23 南京工业大学 一种5’-核苷三磷酸钠盐的结晶方法
WO2017002827A1 (ja) 2015-06-29 2017-01-05 ヤマサ醤油株式会社 Ｐ１，ｐ４－ビス（５'－ウリジル）テトラホスフェート結晶の保管方法
EP3546472B1 (en) * 2016-10-25 2021-06-16 Yamasa Corporation Method for purifying p1,p4-di(uridine 5'-)tetraphosphate
CN111253456B (zh) * 2020-03-13 2021-05-11 广东先强药业有限公司 一种地纽福索钠的制备方法
CN111704637A (zh) * 2020-06-28 2020-09-25 南京工业大学 一种采用膜蒸馏结晶精制核苷酸的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07242685A (ja) * 1994-01-12 1995-09-19 Unitika Ltd ジアデノシン四リン酸水和物の製造方法
US5900407A (en) * 1997-02-06 1999-05-04 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with uridine triphosphates and related compounds
US5837861A (en) * 1997-02-10 1998-11-17 Inspire Pharmaceuticals, Inc. Dinucleotides and their use as modulators of mucociliary clearance and ciliary beat frequency
DK0981534T3 (da) * 1997-02-06 2006-09-04 Inspire Pharmaceuticals Inc Dinukleotider og deres anvendelser
US6596725B2 (en) * 1997-02-10 2003-07-22 Inspire Pharmaceuticals, Inc. Use of certain dinucleotides to stimulate removal of fluid in retinal detachment and retinal edema
TW593331B (en) * 1997-07-25 2004-06-21 Inspire Pharmaceuticals Inc Method for large-scale production of di(uridine 5')-tetraphosphate and salts thereof
JP3723227B2 (ja) * 1997-07-25 2005-12-07 インスパイアー ファーマシューティカルズ，インコーポレイティド ジ（ウリジン５’）−テトラホスフェート及びその塩の大規模生産のための方法
EP1087777B1 (en) * 1998-05-22 2003-02-19 Inspire Pharmaceuticals, Inc. Therapeutic dinucleotide and derivatives
US6458946B1 (en) * 1998-10-02 2002-10-01 Yamasa Corporation Crystals of diuridine tetraphosphate or salt thereof, process for producing the crystals, and process for producing the compounds
WO2000039145A1 (en) * 1998-12-23 2000-07-06 The University Of North Carolina At Chapel Hill Targeted gene transfer using g protein coupled receptors
CZ303172B6 (cs) * 1999-06-30 2012-05-09 Inspire Pharmaceuticals, Inc. Krystalická forma P1-(2'-deoxycytidin-5'-)P4-(uridin-5'-)tetrafosfátu

Also Published As

Publication number Publication date
DE60021629D1 (de) 2005-09-01
ATE300551T1 (de) 2005-08-15
IL147163A0 (en) 2002-08-14
IL147163A (en) 2005-11-20
ZA200110468B (en) 2003-04-04
AU5706700A (en) 2001-01-22
EP1191032A1 (en) 2002-03-27
EA004707B1 (ru) 2004-06-24
BR0012205A (pt) 2002-05-28
NO20016381L (no) 2002-02-28
AU767136B2 (en) 2003-10-30
JP3421666B2 (ja) 2003-06-30
DE60006814D1 (de) 2004-01-08
SK18702001A3 (sk) 2002-06-04
PL202176B1 (pl) 2009-06-30
CA2376860A1 (en) 2001-01-11
SK284178B6 (sk) 2004-10-05
CN1359387A (zh) 2002-07-17
CZ20014502A3 (cs) 2002-05-15
ES2211566T3 (es) 2004-07-16
CZ303172B6 (cs) 2012-05-09
US6617444B1 (en) 2003-09-09
ATE255123T1 (de) 2003-12-15
CA2376860C (en) 2006-11-07
NO20016381D0 (no) 2001-12-27
ES2245431T3 (es) 2006-01-01
WO2001002416A1 (fr) 2001-01-11
PL202200B1 (pl) 2009-06-30
EA200200109A1 (ru) 2002-06-27
KR100593723B1 (ko) 2006-06-30
MXPA02000035A (es) 2003-07-21
DE60021629T2 (de) 2006-01-05
HUP0201531A2 (en) 2002-08-28
NO321169B1 (no) 2006-03-27
NZ516301A (en) 2003-07-25
DE60006814T2 (de) 2004-05-19
EP1191032A4 (en) 2002-07-17
HU229225B1 (en) 2013-09-30
EP1191032B1 (en) 2003-11-26
EP1362862A1 (en) 2003-11-19
EP1362862B1 (en) 2005-07-27
CN1144811C (zh) 2004-04-07
PL352363A1 (en) 2003-08-25
KR20020028903A (ko) 2002-04-17

Similar Documents

Publication Publication Date Title
HUP0100855A3 (en) Fermentative preparation process for cytostatics and crystal forms thereof
HUP9900163A2 (en) Process for the preparation of sterol-and stanol-esters, and use thereof
CZ20012118A3 (cs) Způsob výroby 3-alkanoylindolu a 3-alkylindolu
HUP0201531A3 (en) Dinucleotide crystals and process for preparation thereof
AU6056500A (en) Process and composition for temporarily suppressing pain
EP0990632A4 (en) ADAMANTANEMETHANOL DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF
HK1040421A1 (en) Ornament and method for preparation thereof
AU7446900A (en) Thioalkylamine derivatives and process for the preparation thereof
GB9920271D0 (en) Flavouring agent and methods for preparing and using same
HUP0200003A2 (en) Tetrahydrothiopyran-o-fluorinated phenylcarbamate derivatives and process for their preparation
AU2207001A (en) Novel compounds and process
HUP0203384A3 (en) Process for the preparation of ketimines
IL138691A (en) Process for the preparation of 3-acyl-indoles
HUP0202865A3 (en) Process for the preparation of 2-cyanopyridines
HUP0002751A3 (en) Novel grignard-reagents and process for producing thereof
IL149527A0 (en) Process for the preparation of ketimines
GB9920270D0 (en) Flavouring agent and methods for preparing and using same
HUP0103569A3 (en) New medicament and process for its preparation
AU3841500A (en) Resin-bearing ketoamides and process for the preparation thereof
HK1025951A1 (en) Cephalonsporin crystals and process for their preparation
AU6875800A (en) Heterocyclic compounds and process for the preparation thereof
AU6230499A (en) Method for preparing 2-chloropropionaldehyde and use of the same
IL132524A0 (en) Crystalline form of nefazodone and process for the preparation thereof
AU4781000A (en) 6-hydroxy-2-naphthylcarbinol and process for the preparation thereof
HUP0002028A3 (en) 5-aminopyrazole-4-carboxylate derivatives and process for preparing such compounds

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: INSPIRE PHARMACEUTICALS, INC., US

Free format text: FORMER OWNER(S): YAMASA CORPORATION, JP

GB9A Succession in title

Owner name: MERCK SHARP & DOHME CORP., US

Free format text: FORMER OWNER(S): YAMASA CORPORATION, JP; INSPIRE PHARMACEUTICALS, INC., US

MM4A Lapse of definitive patent protection due to non-payment of fees